{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:57Z","timestamp":1791216057819,"version":"4.1.0"},"reference-count":118,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of HCM, multimodality imaging, by different imaging techniques, such as echocardiography, cardiac magnetic resonance, cardiac computer tomography, and cardiac nuclear imaging, provides essential information for diagnosis, sudden cardiac death stratification, and management. Furthermore, it is essential to uncover the specific cause of HCM, such as Fabry disease and cardiac amyloidosis, which can benefit of specific treatments. This review aims to elucidate the current role of multimodality imaging in adult patients with HCM.<\/jats:p>","DOI":"10.3390\/jcm11030868","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T08:38:48Z","timestamp":1644223128000},"page":"868","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-988X","authenticated-orcid":false,"given":"Emanuele","family":"Monda","sequence":"first","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5102-7460","authenticated-orcid":false,"given":"Giuseppe","family":"Palmiero","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lioncino","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rubino","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapaola","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Fusco","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3805-4170","authenticated-orcid":false,"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Diana","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7060-6938","authenticated-orcid":false,"given":"Alfredo","family":"Mauriello","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Iavarone","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela","family":"Losi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Federico II University of Naples, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"De Rimini","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-4040","authenticated-orcid":false,"given":"Santo","family":"Dellegrottaglie","sequence":"additional","affiliation":[{"name":"Cardiovascular MRI Laboratory, Division of Cardiology, Ospedale Medico-Chirurgico Accreditato Villa dei Fiori, 80011 Acerra, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-9145","authenticated-orcid":false,"given":"Antonello","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"Unit of Cardiology and Intensive Coronary Care, \u201cUmberto I\u201d Hospital, 84014 Nocera Inferiore, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-9950","authenticated-orcid":false,"given":"Eduardo","family":"Bossone","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardarelli Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pacileo","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8291-9517","authenticated-orcid":false,"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1253\/circj.CJ-16-0062","article-title":"From Left Ventricular Hypertrophy to Dysfunction and Failure","volume":"80","author":"Lazzeroni","year":"2016","journal-title":"Circ. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pcad.2009.05.002","article-title":"Clinical impact of left ventricular hypertrophy and implications for regression","volume":"52","author":"Artham","year":"2009","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2020.08.054","article-title":"The hospitalizations in hypertrophic cardiomyopathy: \u201cThe dark side of the moon\u201d","volume":"318","author":"Monda","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/2047487320940863","article-title":"Unexplained sudden cardiac arrest in children: Clinical and genetic characteristics of survivors","volume":"28","author":"Monda","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.hfc.2021.07.002","article-title":"The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention","volume":"18","author":"Monda","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"299","author":"Limongelli","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.hfc.2021.07.006","article-title":"Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"XIX","DOI":"10.1016\/j.hfc.2021.10.001","article-title":"Rare Cardiovascular Diseases: From Genetics to Personalized Medicine","volume":"18","author":"Limongelli","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.hfc.2021.07.005","article-title":"Diagnosis and Management of Cardiovascular Involvement in Fabry Disease","volume":"18","author":"Rubino","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.hfc.2021.07.003","article-title":"Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Caiazza, M., Rubino, M., Monda, E., Passariello, A., Fusco, A., Cirillo, A., Esposito, A., Pierno, A., de Fazio, F., and Pacileo, R. (2020). Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy. Genes, 11.","DOI":"10.3390\/genes11080947"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-7120-8-7","article-title":"Echocardiography in patients with hypertrophic cardiomyopathy: Usefulness of old and new techniques in the diagnosis and pathophysiological assessment","volume":"8","author":"Losi","year":"2010","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s002460010293","article-title":"Quantitation of localized abnormal deformation in asymmetric nonobstructive hypertrophic cardiomyopathy: A velocity, strain rate, and strain Doppler myocardial imaging study","volume":"22","author":"Weidemann","year":"2001","journal-title":"Pediatr. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/eurheartj\/ehm454","article-title":"A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium","volume":"28","author":"Weidemann","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ehjci\/jew005","article-title":"Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy","volume":"17","author":"Haland","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.echo.2020.05.010","article-title":"Myocardial Work in Nonobstructive Hypertrophic Cardiomyopathy: Implications for Outcome","volume":"33","author":"Hiemstra","year":"2020","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/echo.14210","article-title":"Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis","volume":"36","author":"Galli","year":"2019","journal-title":"Echocardiography"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/2047487320934265","article-title":"Yield and clinical significance of genetic screening in elite and amateur athletes","volume":"28","author":"Limongelli","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hfc.2021.01.003","article-title":"Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy","volume":"17","author":"Limongelli","year":"2021","journal-title":"Heart Fail. Clin."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1177\/2047487319888596","article-title":"Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism","volume":"27","author":"Esposito","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"D\u2019Andrea, A., Sperlongano, S., Russo, V., D\u2019Ascenzi, F., Benfari, G., Renon, F., Palermi, S., Ilardi, F., Giallauria, F., and Limongelli, G. (2021). The Role of Multimodality Imaging in Athlete\u2019s Heart Diagnosis: Current Status and Future Directions. J. Clin. Med., 10.","DOI":"10.3390\/jcm10215126"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijcard.2021.06.001","article-title":"Cardiac amyloidosis: Watching the tip of the iceberg emerging from the \u201cheart of the sea\u201d","volume":"338","author":"Amarelli","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Merlo, M., Porcari, A., Pagura, L., Cameli, M., Vergaro, G., Musumeci, B., Biagini, E., Canepa, M., Crotti, L., and Imazio, M. (2021). A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: Study design and patients characterization-the first insight from the AC-TIVE Study. Eur. J. Prev. Cardiol., zwab127.","DOI":"10.1093\/eurjpc\/zwab127"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.hfc.2021.07.014","article-title":"The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis","volume":"18","author":"Palmiero","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Liu, D., Hu, K., Niemann, M., Herrmann, S., Cikes, M., St\u00f6rk, S., Beer, M., Gaudron, P.D., Morbach, C., and Knop, S. (2013). Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056923"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e005588","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijcard.2021.10.153","article-title":"Left ventricular rotational mechanics in cardiac amyloidosis\u2014Reply","volume":"345","author":"Monda","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2021.07.035","article-title":"External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis","volume":"339","author":"Monda","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13449","DOI":"10.1111\/eci.13449","article-title":"A simple echocardiographic score to rule out cardiac amyloidosis","volume":"51","author":"Aimo","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.echo.2019.11.018","article-title":"Left Ventricular Pressure-Strain-Derived Myocardial Work at Rest and during Exercise in Patients with Cardiac Amyloidosis","volume":"33","author":"Clemmensen","year":"2020","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ehjci\/jeaa097","article-title":"Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis","volume":"22","author":"Clemmensen","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e001346","DOI":"10.1136\/openhrt-2020-001346","article-title":"Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?","volume":"7","author":"Cariou","year":"2020","journal-title":"Open Heart"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/jcecho.jcecho_16_21","article-title":"Global Left Ventricular Myocardial Work Efficiency in Heart Failure Patients with Cardiac Amyloidosis: Pathophysiological Implications and Role in Differential Diagnosis","volume":"31","author":"Palmiero","year":"2021","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: Potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2362.2008.01921.x","article-title":"Misleading terms in Anderson-Fabry disease","volume":"38","author":"Weidemann","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kr\u00e4mer, J., Bijnens, B., St\u00f6rk, S., Ritter, C.O., Liu, D., Ertl, G., Wanner, C., and Weidemann, F. (2015). Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140627"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/echo.13496","article-title":"Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?","volume":"34","author":"Labombarda","year":"2017","journal-title":"Echocardiography"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12968-019-0557-0","article-title":"Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: Relationship to T1 mapping, late gadolinium enhancement and hypertrophy","volume":"21","author":"Mathur","year":"2019","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ehjci\/jey108","article-title":"Prominent longitudinal strain reduction of left ventricular basal segments in treatment-na\u00efve Anderson-Fabry disease patients","volume":"20","author":"Esposito","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10554-020-02105-y","article-title":"Does left ventricular function predict cardiac outcome in Anderson-Fabry disease?","volume":"37","author":"Spinelli","year":"2021","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2217\/fca-2020-0107","article-title":"Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy","volume":"17","author":"Monda","year":"2021","journal-title":"Futur. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/ehjci\/jeaa329","article-title":"Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: The ESC EORP Cardiomyopathy\/Myocarditis Registry","volume":"22","author":"Charron","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2008.04.047","article-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"52","author":"Olivotto","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ehjci\/jes145","article-title":"Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: Comparison with transthoracic echocardiography","volume":"14","author":"Puntmann","year":"2013","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/hrt.2003.014969","article-title":"Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography","volume":"90","author":"Moon","year":"2004","journal-title":"Heart"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ehjci\/jes005","article-title":"Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers","volume":"13","author":"Brouwer","year":"2012","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"Grasso","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: Accurate reflection of histopathological findings by CMR","volume":"6","author":"Moravsky","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jcmg.2012.10.028","article-title":"Contrast-enhanced CMR in HCM: What lies behind the bright light of LGE and why it now matters","volume":"6","author":"Maron","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic Value of LGE-CMR in HCM: A Meta-Analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function","volume":"72","author":"Mentias","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management","volume":"69","author":"Rowin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12968-016-0242-5","article-title":"A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: Experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data","volume":"18","author":"Engblom","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2589-7500(20)30267-3","article-title":"Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: A comparison with human test-retest performance","volume":"3","author":"Augusto","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"20190634","DOI":"10.1259\/bjr.20190634","article-title":"MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: Tissue remodeling manifested prior to structure changes","volume":"92","author":"Huang","year":"2019","journal-title":"Br. J. Radiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/j.ejrad.2012.12.014","article-title":"T1 mapping for detection of left ventricular myocardial fibrosis in hypertrophic cardiomyopathy: A preliminary study","volume":"82","author":"Lu","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.2019190651","article-title":"MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction","volume":"294","author":"Xu","year":"2020","journal-title":"Radiology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","article-title":"Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping","volume":"52","author":"Iles","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2016.02.018","article-title":"Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction","volume":"67","author":"Rommel","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e3853","DOI":"10.1002\/nbm.3853","article-title":"Cardiovascular magnetic resonance elastography: A review","volume":"31","author":"Khan","year":"2018","journal-title":"NMR Biomed."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: Consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_81","first-page":"1673","article-title":"Proposed Stages of Myocardial Phenotype Development in Fabry Disease","volume":"12","author":"Nordin","year":"2019","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"ref_83","first-page":"488","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: An equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.hfc.2021.07.001","article-title":"Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia","volume":"18","author":"Monda","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"632293","DOI":"10.3389\/fped.2021.632293","article-title":"Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes","volume":"9","author":"Monda","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"696443","DOI":"10.3389\/fped.2021.696443","article-title":"Editorial: Paediatric Cardiomyopathies","volume":"9","author":"Monda","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jcct.2014.09.007","article-title":"Utility of coronary CT angiography in outpatients with hypertrophic cardiomyopathy presenting with angina symptoms","volume":"8","author":"Shariat","year":"2014","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/heart.89.7.791","article-title":"Cardiac abnormalities in patients with Leber\u2019s hereditary optic neuropathy","volume":"89","author":"Sorajja","year":"2003","journal-title":"Heart"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","article-title":"Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations","volume":"58","author":"Olivotto","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ehjci\/jeu291","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: An expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association","volume":"16","author":"Cardim","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-9149(89)90428-1","article-title":"Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy","volume":"64","author":"Prisant","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.76.6.1214","article-title":"Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: Assessment with thallium-201 emission computed tomography","volume":"76","author":"Bonow","year":"1987","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s12350-018-1298-4","article-title":"Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?","volume":"26","author":"Bravo","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2967\/jnumed.111.096156","article-title":"PET\/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"53","author":"Bravo","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Brancaccio, M., Mennitti, C., Cesaro, A., Monda, E., D\u2019Argenio, V., Casaburi, G., Mazzaccara, C., Ranieri, A., Fimiani, F., and Barretta, F. (2021). Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge. Diagnostics, 11.","DOI":"10.3390\/diagnostics11112144"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/eurheartj\/ehp121","article-title":"Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death","volume":"30","author":"Basso","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2007.12.038","article-title":"Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis","volume":"51","author":"Rapezzi","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.06.006","article-title":"Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population","volume":"270","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A Routine PET\/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e002954","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study","volume":"8","author":"Park","year":"2015","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","article-title":"Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: More than hearts and minds","volume":"45","author":"Wagner","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_112","first-page":"1652","article-title":"Imaging cardiac amyloidosis: A pilot study using \u00b9\u2078F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00259-017-3778-1","article-title":"Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease","volume":"44","author":"Imbriaco","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.2004.054015","article-title":"Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10545-006-0221-3","article-title":"The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease","volume":"29","author":"Kalliokoski","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ehjci\/jez039","article-title":"Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group","volume":"20","author":"Imbriaco","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Monda, E., Palmiero, G., Rubino, M., Verrillo, F., Amodio, F., di Fraia, F., Pacileo, R., Fimiani, F., Esposito, A., and Cirillo, A. (2020). Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186462"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/868\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:15:29Z","timestamp":1760134529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/3\/868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":118,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["jcm11030868"],"URL":"https:\/\/doi.org\/10.3390\/jcm11030868","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]}}}